Life Science Company News

Reset
Results 441 - 460 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22 23  24  25 »

Oculis Announces Appointment of Daniel S. Char as Chief Legal Officer

Read more ››
By: GlobeNewswire - 02 Oct 2024
Related companies:  Oculis Holding AG

The Ensign Group Acquires Healthcare Campus in Nebraska

Read more ››
By: GlobeNewswire - 02 Oct 2024

Curve Therapeutics further strengthens leadership team with the appointment of Andre Hoekema as new Chair of Board

Read more ››
By: PR Newswire Association LLC. - 02 Oct 2024
Related companies:  Curve Therapeutics

LoQus23 Therapeutics announces £35 million (c.$43 million) Series A financing to advance its small molecule somatic expansion inhibition therapy for Huntington's disease

Read more ››
By: PR Newswire Association LLC. - 02 Oct 2024
Related companies:  LoQus23 Therapeutics Ltd.

Immunovia completes analytical validation of its next-generation pancreatic cancer test

Read more ››
By: PR Newswire Association LLC. - 02 Oct 2024
Related companies:  Immunovia AB

SyntheticMR Receives Regulatory Approval for SyMRI 15 in Switzerland

Read more ››
By: PR Newswire Association LLC. - 02 Oct 2024
Related companies:  SyntheticMR AB

Dads Go Wild Returns for 2024 with Focus on Mental Health, Fatherhood, and Community

Read more ››
By: PR Newswire Association LLC. - 02 Oct 2024

CARBIOS announces half-year 2024 financial results and presents its industrial and commercial progress

Read more ››
By: GlobeNewswire - 02 Oct 2024
Related companies:  Carbios SA

EssilorLuxottica Completes Acquisition of a Majority Stake in Heidelberg Engineering

Read more ››
By: GlobeNewswire - 02 Oct 2024
Related companies:  EssilorLuxottica

EssilorLuxottica Completes Acquisition of Supreme® from VF Corporation

Read more ››
By: GlobeNewswire - 02 Oct 2024
Related companies:  EssilorLuxottica

APAC LIVER DISEASE ALLIANCE HOSTS "HEP-FREE: ELIMINATING ASIA'S SILENT PUBLIC HEALTH THREAT BY 2030" SUMMIT IN BANGKOK ON 1 OCTOBER 2024

Read more ››
By: PR Newswire Association LLC. - 02 Oct 2024

Once-daily RELEXXII® (methylphenidate hydrochloride extended-release tablet) proudly supports Attention Deficit Hyperactivity Disorder (ADHD) Awareness Month

Read more ››
By: PR Newswire Association LLC. - 02 Oct 2024
Related companies:  Alora Pharmaceuticals, LLC.

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 02 Oct 2024
Related companies:  LENSAR, Inc.

APSHO Honored with ASAE Summit Award for Advancing Healthcare Excellence

Read more ››
By: PR Newswire Association LLC. - 02 Oct 2024

VALEO PHARMA INITIATES RESTRUCTURING PROCEEDINGS UNDER THE CCAA TO IMPLEMENT A REVIEW OF ITS STRATEGIC ALTERNATIVES

Read more ››
By: PR Newswire Association LLC. - 02 Oct 2024
Related companies:  Valeo Pharma Inc.

Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)

Read more ››
By: GlobeNewswire - 01 Oct 2024
Related companies:  Arch Therapeutics, Inc.

Clene Announces Closing of $7.3 Million Registered Direct Offering and Concurrent Private Placements and Amendment of Debt Facility

Read more ››
By: GlobeNewswire - 01 Oct 2024
Related companies:  Clene Inc.

Stryker to announce its third quarter 2024 financial results

Read more ››
By: GlobeNewswire - 01 Oct 2024
Related companies:  Stryker Corporation

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

Read more ››
By: GlobeNewswire - 01 Oct 2024
Related companies:  ADC Therapeutics SA

Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date

Read more ››
By: GlobeNewswire - 01 Oct 2024
Related companies:  Myriad Genetics, Inc.
Results 441 - 460 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22 23  24  25 »

Enhance your business development with Biotechgate
Try for free »